Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study

Summary

The purpose of this study is to evaluate the safety and efficacy of teduglutide treatment of children with short bowel syndrome (SBS) who completed the TED-C13-003 study over a long-term period. It will evaluate how these children fared after the TED-C13-003 study ended. This study will also offer teduglutide treatment to eligible subjects, regardless of treatment received in TED-C13-003.

Timeline

Start

2016-12-09

Primary completion

2020-07-14

Completion

2020-07-14

Publications

• Wendel D, Wales PW, Kocoshis S, Venick R, Carter B, Cohran V, Matthews C, Raphael BP, Robinson I, Hill S. Quality of life for pediatric patients with short bowel syndrome-associated intestinal failure treated with teduglutide. J Pediatr Gastroenterol Nutr. 2026 Jul;83(1):54-62. doi: 10.1002/jpn3.70358. Epub 2026 Mar 19.

Drugs

Indications